This inventor holds 1 USPTO granted patent. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: Christiane Bornmann: Innovator in Pharmaceutical Development
Introduction
Christiane Bornmann is a notable inventor based in Gemünden, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the area of hemostasis therapy. Her innovative work has led to the development of a unique pharmaceutical agent that utilizes tissue protein PP4.
Latest Patents
Christiane Bornmann holds 1 patent related to her research. The patent describes a pharmaceutical containing tissue protein PP4, which is aimed at the therapy or prophylaxis of disturbances of hemostasis. The patent outlines a process for the purification of PP4 using a hydrophobic adsorbent that is insoluble in water. Additionally, it details a method for the pasteurization of a solution containing PP4 in the presence of calcium ions and at least one mono- or oligosaccharide or sugar alcohol, and potentially an amino acid. The use of PP4 in therapeutic applications is also highlighted in her patent.
Career Highlights
Christiane Bornmann is associated with Behringwerke Aktiengesellschaft, a company known for its advancements in biopharmaceuticals. Her work at the company has been instrumental in developing innovative solutions for medical challenges related to blood coagulation.
Collaborations
Christiane collaborates with Hartmut Lobermann, contributing to the advancement of their shared research interests in pharmaceuticals.
Conclusion
Christiane Bornmann's contributions to pharmaceutical innovation, particularly through her patent on tissue protein PP4, underscore her role as a key figure in the field. Her work continues to influence therapeutic approaches to hemostasis disturbances.